Flecainide- NTID [Design Issues]

posted by dr.who – Macedonia, 2018-06-28 01:32 (1738 d 04:38 ago) – Posting: # 18985
Views: 2,992

Thanks for the feedback.

Yes,you are right. All availabe PARS show BE with standard acceptance limits.

But, the originator SmPC states that flecainide is NTID:
"Flecainide as a narrow therapeutic index drug requires caution and close monitoring when switching a patient to a different formulation."

https://www.medicines.org.uk/emc/product/829/smpc

Also, I found this study which consider the NTI for flecainide and regulatory requirements per region.\
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412688/

Complete thread:

UA Flag
Activity
 Admin contact
22,559 posts in 4,725 threads, 1,607 registered users;
27 visitors (0 registered, 27 guests [including 13 identified bots]).
Forum time: 06:10 CEST (Europe/Vienna)

The penalty for scientific irrelevance is, of course,
that the statistician’s work is ignored by the scientific community.    George E.P. Box

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5